MAPK15 and granular cell tumor: In light of our findings, MAPK15-specific inhibitors might, therefore, represent new tools to enhance the therapeutic index of cytotoxic therapy in GCT treatment and to increase sensitivity to DNA-damaging agents in chemotherapy-resistant GCT subsets and in other human tumors with acquired or intrinsic resistance.